What's breaking now, across thousands of outlets.
Biotechnology company Antengene Corporation dosed the first patient in its Phase III CLINCH 3 trial evaluating antibody drug conjugate ATG 022 for treating advanced gastric or gastroesophageal junction adenocarcinoma
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.
In this GEN Learning Lab, our expert panelists Guangping Gao, PhD, and Thomas Quinn will explore critical steps in the AAV workflow that influence vector quality and downstream experimental success.
Two-thirds of B.C. doctors said they do not feel their workplace effectively addresses situations that may threaten or harm employees.
[Daily News] Dar es Salaam -- PRESIDENT Samia Suluhu Hassan, an African Union champion for maternal and child health is expected to convene African leaders and development partners in New York on…
The Accra Reset has unveiled a new blueprint for restructuring global health financing and governance, with countries being urged to read more Accra Reset unveils plan to shift global health financing…
By: Jennifer Nerkie Kenney The Deputy Minister for Health, Prof. Dr. Grace Ayensu-Danquah, has appealed to the Bono Regional Minister, Hon.
Indonesia has recorded 174,694 acute respiratory infection cases in areas affected by forest and land fires since August 18, including 40,363 in child
